Latest Commercialization News

Sequoia Financial Group Ltd has admitted to unintentionally breaching ASX Listing Rule 15.7 after its CEO disclosed details of the InterPrac Financial Planning sale to a journalist during a trading halt. The company is reviewing its continuous disclosure practices to prevent future occurrences.

Aguia Resources’ Brazilian subsidiary has achieved a key regulatory milestone with official fertiliser registration, enabling commercial sales of its PAMPAFOS phosphate product in Brazil’s large agricultural market.

Greenvale Energy Limited has completed a key milestone in its Alpha Torbanite Project test program, progressing towards producing certified bitumen products amid tightening Australian bitumen markets.

Imricor Medical Systems has submitted its NorthStar Mapping System for FDA pediatric label expansion, aiming to accelerate adoption in over 250 US children’s hospitals and broaden its commercial footprint.

G50 Corp Limited reports encouraging metallurgical test results from its Golconda Project in Arizona, demonstrating the ability to concentrate gallium using established, cost-effective processing techniques. The findings support the potential for a strategic domestic gallium supply integrated with precious metals production.

White Cliff Minerals has announced metallurgical test results from its Danvers deposit in Nunavut, Canada, showing copper recoveries exceeding 95% and high-grade concentrates produced via conventional flotation without regrinding. These findings support a lower-cost, scalable processing route and coincide with ongoing exploration along the Teshierpi Fault Zone.

Vitrafy Life Sciences has announced the completion of Phase II testing of a platelet cryopreservation study with the U.S. Army Institute of Surgical Research, showing consistent results for the legacy wash-based protocol and encouraging outcomes for an innovative no-wash approach.

Temas Resources Corp has appointed chemical process expert Dr. Santiago Faucher to its Scientific Advisory Board, enhancing the technical and commercialisation capabilities of its Regenerative Chloride Leaching (RCL) technology. This move supports the company’s strategy to advance its innovative hydrometallurgical platform and complements its mineral project developments in Québec.

Predictive Discovery Limited (ASX: PDI) and Robex Resources Inc. (ASX: RXR) have confirmed their merger is unconditional and moving to implementation, forming a significant West African gold producer with combined assets targeting over 400,000 ounces of gold production annually by 2029.

Orbital UAV has entered the Middle East market with a USD 1.1 million order from a UAE sovereign government for its 50HFE propulsion systems and signed a long-term distribution agreement to expand its UAV propulsion presence.

Archer Materials has progressed its Biochip program by completing the alpha prototype and Stage 1 project with IMEC, now advancing to develop a beta prototype suitable for external use and clinical validation.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.